why choose us

First received: August 02, 2023

Clinical Trial: Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Study Status: Completed

Recruit Status: RECRUITING

Condition: Kidney Transplant Rejection

Study Type: INTERVENTIONAL


Official Title: AT-1501-K207: BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Brief Summary: This study will evaluate the safety and efficacy of AT-1501 compared with tacrolimus in patients undergoing kidney transplantation.

Read more